$1.05 Billion is the total value of HARBOURVEST PARTNERS LLC's 51 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| W | Wayfair, Inc. | $335,324,000 | +0.3% | 1,062,126 | 0.0% | 32.05% | -28.5% | |
| SWI | Solarwinds Corp. | $125,648,000 | -3.2% | 7,439,200 | 0.0% | 12.01% | -31.0% | |
| EVLO | Evelo Biosciences, Inc. | $42,093,000 | +28.4% | 3,063,505 | 0.0% | 4.02% | -8.5% | |
| RUBY | Rubius Therapeutics, Inc. | $24,090,000 | -7.9% | 986,878 | 0.0% | 2.30% | -34.3% | |
| KLDO | Kaleido BioSciences, Inc. | $13,644,000 | -8.1% | 1,833,832 | 0.0% | 1.30% | -34.5% | |
| AXLA | Axcella Health, Inc. | $11,260,000 | -15.8% | 2,807,981 | 0.0% | 1.08% | -40.0% | |
| RLAY | Relay Therapeutics, Inc. | $10,845,000 | +5.8% | 296,402 | 0.0% | 1.04% | -24.5% | |
| LC | LendingClub Corp. | $9,309,000 | +9.8% | 513,440 | 0.0% | 0.89% | -21.8% | |
| SGTX | Sigilon Therapeutics, Inc. | $7,948,000 | -52.0% | 740,740 | 0.0% | 0.76% | -65.8% | |
| TWLO | Twilio, Inc. | $5,744,000 | +15.7% | 14,572 | 0.0% | 0.55% | -17.6% | |
| LOV | Spark Networks SEsponsored adr | $2,595,000 | -30.5% | 501,026 | 0.0% | 0.25% | -50.5% | |
| U | Unity Software | $2,405,000 | +9.5% | 21,899 | 0.0% | 0.23% | -22.0% | |
| AFRM | Affirm, Inc. | $1,889,000 | -4.8% | 28,053 | 0.0% | 0.18% | -32.0% | |
| YEXT | Yext, Inc. | $1,645,000 | -1.3% | 115,147 | 0.0% | 0.16% | -29.9% | |
| MCRB | Seres Therapeutics, Inc. | $1,177,000 | +15.8% | 49,363 | 0.0% | 0.11% | -16.9% | |
| CSLT | Castlight Health, Inc. | $918,000 | +74.2% | 349,070 | 0.0% | 0.09% | +23.9% | |
| PACB | Pacific Biosciences of California, Inc. | $821,000 | +5.0% | 23,484 | 0.0% | 0.08% | -25.7% | |
| DCT | Duck Creek Technologies, Inc. | $631,000 | -3.7% | 14,508 | 0.0% | 0.06% | -31.8% | |
| CTMX | Cytomx Therapeutics, Inc. | $501,000 | -18.1% | 79,193 | 0.0% | 0.05% | -41.5% | |
| TRVN | Trevena, Inc. | $395,000 | -5.7% | 233,850 | 0.0% | 0.04% | -32.1% | |
| YMTX | Yumanity | $257,000 | -35.6% | 22,030 | 0.0% | 0.02% | -53.7% | |
| PMVP | PMV Pharmaceuticals | $263,000 | +4.0% | 7,692 | 0.0% | 0.02% | -26.5% | |
| EPZM | Epizyme, Inc. | $205,000 | -4.7% | 24,686 | 0.0% | 0.02% | -31.0% | |
| NXTC | NextCure, Inc. | $81,000 | -19.8% | 10,044 | 0.0% | 0.01% | -42.9% | |
| METC | Ramaco Resources, Inc. | $82,000 | +30.2% | 14,951 | 0.0% | 0.01% | 0.0% | |
| HNRG | Hallador Energy Resources, Inc. | $38,000 | +40.7% | 14,270 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.